Author: Elste, James; Kaltenbach, Dominik; Patel, Vraj R.; Nguyen, Max T.; Sharthiya, Harsh; Tandon, Ritesh; Mehta, Satish K.; Volin, Michael V.; Fornaro, Michele; Tiwari, Vaibhav; Desai, Umesh R.
Title: Inhibition of Human Cytomegalovirus Entry into Host Cells through A Pleiotropic Small Molecule Document date: 2020_2_29
ID: 031ro01b_4
Snippet: One group of receptors that could be targeted by such agents include the heparan sulfate proteoglycans. First, HCMV glycoproteins, especially gB, are known to bind to HS chains present on these cell surface proteoglycans [41] . Thus, appropriate competitive molecules would be expected to reduce cellular attachment and entry. Second, many host cell surface receptors are also known to bind to HS such as growth factor receptors (e.g., PDGF-R and EGF.....
Document: One group of receptors that could be targeted by such agents include the heparan sulfate proteoglycans. First, HCMV glycoproteins, especially gB, are known to bind to HS chains present on these cell surface proteoglycans [41] . Thus, appropriate competitive molecules would be expected to reduce cellular attachment and entry. Second, many host cell surface receptors are also known to bind to HS such as growth factor receptors (e.g., PDGF-R and EGF-R) and neuropilin [28] , which could offer additional opportunities for competitive inhibition. Third, inhibitors of viral entry could be expected to have downstream consequences such as the expression of viral immediate-early genes, whose products play a key role in the pathogenesis of HCMV infection, and prevention or reduction in host immunomodulation [42] .
Search related documents:
Co phrase search for related documents- host cell and immediate early gene: 1, 2, 3
- host cell and key role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60
- host cell surface and HS chain: 1, 2
- host cell surface and key role: 1, 2, 3, 4, 5, 6, 7
- host cell surface and sulfate proteoglycan: 1, 2
- host cell surface and viral entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
- host cell surface receptor and key role: 1, 2, 3
- host cell surface receptor and viral entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- host immunomodulation and immediate early gene: 1
- host immunomodulation and key role: 1
- host immunomodulation and viral entry: 1
- HS chain and viral entry: 1
- immediate early gene and key role: 1, 2
- immediate early gene and viral entry: 1, 2, 3, 4, 5, 6
- key role and viral entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- key role and viral entry inhibitor: 1
- receptor group and viral entry: 1, 2
- reduction prevention and viral entry: 1
- sulfate proteoglycan and viral entry: 1
Co phrase search for related documents, hyperlinks ordered by date